https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2021-08-12 10:57:142023-06-14 15:53:23Arix Bioscience plc Interim results for the six months ended 30 June 2021
https://www.optimumcomms.com/wp-content/uploads/2023/05/OPT_Logo_300x180px-80x80Web_Logos.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2021-06-30 18:35:062023-06-14 15:53:36Optimum Strategic Communications Expands Team to support ongoing growth
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2021-03-19 08:46:312023-06-14 15:53:44Novo Holdings posts record income and returns of DKK 29 billion (EUR 4 billion) in 2020
https://www.optimumcomms.com/wp-content/uploads/2023/05/OPT_Logo_300x180px-80x80Web_Logos.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-10-23 17:43:262023-06-14 16:01:52Niall Kirk, Friend and Founder of Optimum Strategic Communications
https://www.optimumcomms.com/wp-content/uploads/2023/05/OPT_Logo_300x180px-80x80Web_Logos.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-10-05 15:29:312023-06-14 16:03:47Optimum Strategic Communications 12th Annual Healthcare Investor Conference
https://www.optimumcomms.com/wp-content/uploads/2023/05/OPT_Logo_300x180px-80x80Web_Logos.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-07-17 13:57:472023-06-14 16:09:06Optimum recognised for its work in the M&A PR advisor league tables
https://www.optimumcomms.com/wp-content/uploads/2023/05/OPT_Logo_300x180px-80x80Web_Logos.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-05-20 10:23:012023-06-14 16:05:47Optimum European Healthcare Investor Survey
https://www.optimumcomms.com/wp-content/uploads/2020/05/Brochure-Cover-image.jpg
281
500
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-05-20 09:00:562022-09-30 11:05:44Optimum European Healthcare Investor Survey
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-01-10 15:21:462023-06-14 16:00:01Verona Pharma to Report 4 Week Phase 2b COPD Dose-ranging Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-01-09 15:19:182023-06-14 15:46:27Macrophage Pharma Expands Executive Team with Chief Scientific Officer and Chief Technology Officer
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-01-08 15:15:262023-06-14 15:46:36Ori Biotech announces a $9.4M seed round to advance innovation in Cell and Gene Therapy manufacturing
https://www.optimumcomms.com/wp-content/uploads/2023/05/OPT_Logo_300x180px-80x80Web_Logos.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-01-08 09:05:572023-06-14 16:06:01Optimum Strategic Communications Expands Team with Appointment of Shabnam Bashir
https://www.optimumcomms.com/wp-content/uploads/2023/02/Verona_Logo_300-1.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2020-01-07 15:20:132023-06-14 16:15:22Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-18 10:06:582023-06-14 16:07:30Edinburgh Molecular Imaging Closes Financing
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-11 09:43:262023-06-14 16:07:37Forendo Pharma signs important License and Collaboration Deal with Leading Pharma Company
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-09 17:29:392023-06-14 16:07:41STORM Therapeutics’ collaborator awarded ASH–BSH Abstract Achievement Award at the 61st ASH Annual Meeting & Exposition
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-09 17:27:552023-06-14 16:13:40ImaginAb Initiates Phase II Clinical Trial at Penn Medicine
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-05 09:44:532023-06-14 16:14:04Takeda and Enzyre to Develop Diagnostic Device Allowing Hemophilia Patients to Determine their Coagulation Status at Home
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-02 11:46:512023-06-14 16:13:35IXICO to Present Abstracts at Upcoming Clinical Trials on Alzheimer’s Disease Congress
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-12-02 11:31:422023-06-14 16:07:49Owkin Teams up with NVIDIA and King’s College London to Deliver AI to Hospitals While Protecting Patient Data With Federated LearningFor more information about Optimum Strategic Communications, please get in touch.
